F41D3.14

Caenorhabditis elegans

Is affected by ahr-1; fzo-1; and mip-1 based on RNA-seq studies.

C26H9A.3

Caenorhabditis elegans

Is affected by several genes including mip-1; set-6; and hda-1 based on RNA-seq studies.

Y116A8C.467

Caenorhabditis elegans

Is affected by several genes including swsn-1; mip-1; and daf-2 based on microarray and RNA-seq studies.

linc-93

Caenorhabditis elegans

Is affected by several genes including spr-5; mip-1; and ogt-1 based on RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

W04E12.10

Caenorhabditis elegans

Is affected by clk-1; hlh-26; and mip-1 based on microarray and RNA-seq studies. Is affected by paraquat based on RNA-seq studies.

F41D3.8

Caenorhabditis elegans

Is affected by several genes including cyc-1; mrps-5; and mip-1 based on microarray and RNA-seq studies. Is affected by resveratrol based on microarray studies.

Y116A8C.468

Caenorhabditis elegans

Is affected by damt-1; alh-4; and mip-1 based on RNA-seq studies. Is affected by four chemicals including antimycin; Doxycycline; and Tamoxifen based on RNA-seq studies.

F28A10.2

Caenorhabditis elegans

Enriched in male based on RNA-seq studies. Is affected by several genes including rsr-2; hmg-3; and mip-1 based on tiling array; RNA-seq; and microarray studies. Is affected by seven chemicals including multi-walled carbon nanotube; Psoralens; and allantoin based on RNA-seq and microarray studies.

R105.4

Caenorhabditis elegans

Is affected by several genes including unc-30; mip-1; and let-418 based on microarray and RNA-seq studies. Is affected by paraquat and Doxorubicin based on RNA-seq studies.

Y53F4B.63

Caenorhabditis elegans

Is affected by mip-1; ogt-1; and nuo-6 based on RNA-seq and microarray studies. Is affected by six chemicals including rifampin; Sirolimus; and allantoin based on RNA-seq and microarray studies.